The most important thing is to identify hazards, and hazards must be identified before you can analyze them.
GOOD DISTRIBUTION PRACTICES
With jumps in e-commerce volume and complexity, manufacturers must address challenges in shipping, communicating with third-party retailers, and secon...
CBER offers information on how to handle temperature-sensitive biologics in power outages or floods.
PDA’s Berlin conference sheds light on manufacturing and logistics, serialization, and regulatory pressure for temperature control of warehouses and...
True or false questions about the handling of biologics and drugs in the supply chain.
Part of a $5.4 million grant will go to boosting cold chain and logistic personnel.
Pharma EXPO presenter addresses key architectural and organizational questions that manufacturers need to consider in building serialization programs.
Chapter <1083> Good Distribution Practices expanding scope to include APIs, excipients, dietary supplements, and more.
Kevin O’Donnell, Senior Partner, Exelsius, is a noted authority in supply chain integrity. In this Q&A he lends his “big-picture” insights r...